Provided by Tiger Fintech (Singapore) Pte. Ltd.

Brainstorm Cell Therapeutics

1.22
+0.09007.96%
Post-market: 1.19-0.0300-2.46%19:30 EDT
Volume:518.91K
Turnover:608.83K
Market Cap:9.65M
PE:-0.53
High:1.22
Open:1.13
Low:1.12
Close:1.13
Loading ...

Brainstorm Cell Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
31 Mar

Press Release: BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update

Dow Jones
·
31 Mar

Brainstorm Cell Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
28 Mar

Brainstorm Cell Therapeutics Granted Compliance Extension From Nasdaq

THOMSON REUTERS
·
26 Mar

BrainStorm Cell Therapeutics Granted Compliance Extension from Nasdaq

PR Newswire
·
26 Mar

Brainstorm to Announce Fourth Quarter and Fiscal Year 2024 Financial Results and Provide a Corporate Update

THOMSON REUTERS
·
24 Mar

BrainStorm to Announce Fourth Quarter and Fiscal Year 2024 Financial Results and Provide a Corporate Update

PR Newswire
·
24 Mar

BCLI: Plans Coming Together for Phase 3b Trial of NurOwn® in ALS…

Zacks Small Cap Research
·
06 Jan

BrainStorm Issues 2024 Letter to Shareholders

PR Newswire
·
30 Dec 2024

Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD) and Brainstorm Cell Therapeutics (BCLI)

TIPRANKS
·
15 Dec 2024

Brainstorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update

THOMSON REUTERS
·
09 Dec 2024

BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update

PR Newswire
·
09 Dec 2024

BRIEF-Brainstorm Strengthens Exosome Patent Portfolio, Receives Notice Of Allowance For U.S. Patent Covering Its Platform Technology

Reuters
·
03 Dec 2024

BrainStorm receives Notice of Allowance for patent on exosome technology

TIPRANKS
·
03 Dec 2024

Brainstorm: Strengthens Exosome Patent Portfolio, Receives Notice of Allowance for U.S. Patent Covering Its Platform Technology

THOMSON REUTERS
·
03 Dec 2024

BrainStorm Strengthens Exosome Patent Portfolio: Receives Notice of Allowance for U.S. Patent Covering Its Platform Technology

PR Newswire
·
03 Dec 2024

BrainStorm Cell Therapeutics to Host KOL Webinar on Current Developments in the Treatment of Amyotrophic Lateral Sclerosis (ALS) on December 11, 2024

PR Newswire
·
02 Dec 2024